OBESITY AND ADVERSE CARDIAC REMODELING IN HFPEF: THE PARAGON-HF TRIAL

被引：0
|
作者：
Wang, Xiaowen [1 ]
Ostrominski, John [1 ]
Litwin, Sheldon E. [1 ]
Cikes, Maja [1 ]
Merkely, Bela [1 ]
Kosztin, Annamaria [1 ]
Mullens, Wilfried [1 ]
Inciardi, Riccardo M. [1 ]
Peikert, Alexander [1 ]
Pabon, Maria [1 ]
Hegde, Sheila M. [1 ]
Skali, Hicham [1 ]
Shah, Amil M. [1 ]
Claggett, Brian [1 ]
Packer, Milton [1 ]
Pfeffer, Marc A. [1 ]
McMurray, John J. V. [1 ]
Solomon, Scott D. [1 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1548-184
引用
收藏
页码：1575 / 1575
页数：1
相关论文
共 50 条
  • [41] ARNI and MRA Combination in PARAGON-HF Odd Couple or Dynamic Duo?
    Riello, Ralph J.
    Pitt, Bertram
    JACC-HEART FAILURE, 2021, 9 (01) : 25 - 27
  • [42] SACUBITRIL/VALSARTAN, TREATMENT-RELATED HYPOTENSION, AND LEFT VENTRICULAR EJECTION FRACTION IN THE PARAGON-HF TRIAL
    Foa, Alberto
    Claggett, Brian
    Pabon, Maria
    Lu, Henri
    Pfeffer, Marc A.
    Packer, Milton
    Vardeny, Orly
    Rouleau, Jean L.
    Lefkowitz, Martin
    Jhund, Pardeep S.
    Desai, Akshay S.
    Vaduganathan, Muthiah
    McMurray, John J. V.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 376 - 376
  • [43] Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trial
    Lund, Lars H.
    Savarese, Gianluigi
    Venkateshvaran, Ashwin
    Benson, Lina
    Lundberg, Anna
    Donal, Erwan
    Daubert, Jean-Claude
    Oger, Emmanuel
    Linde, Cecilia
    Hage, Camilla
    ESC HEART FAILURE, 2022, 9 (01): : 164 - 177
  • [44] Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial
    Desai, Akshay S.
    Vaduganathan, Muthiah
    Cleland, John G.
    Claggett, Brian L.
    Barkoudah, Ebrahim
    Finn, Peter
    McCausland, Finnian R.
    Yilmaz, Mehmet B.
    Lefkowitz, Martin
    Shi, Victor
    Pfeffer, Marc A.
    McMurray, John J. V.
    Solomon, Scott D.
    CIRCULATION-HEART FAILURE, 2021, 14 (12) : 1283 - 1290
  • [45] Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON-HF trial
    Chatur, Safia
    Claggett, Brian L.
    Vardeny, Orly
    Jering, Karola
    Desai, Akshay S.
    Pfeffer, Marc A.
    Lefkowitz, Martin
    McMurray, John J., V
    Solomon, Scott D.
    Vaduganathan, Muthiah
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (01) : 87 - 94
  • [46] Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction The PARAGON-HF Trial
    Chandra, Alvin
    Vaduganathan, Muthiah
    Lewis, Eldrin F.
    Claggett, Brian L.
    Rizkala, Adel R.
    Wang, Wenyan
    Lefkowitz, Martin P.
    Shi, Victor C.
    Anand, Inder S.
    Ge, Junbo
    Lam, Carolyn S. P.
    Maggioni, Aldo P.
    Martinez, Felipe
    Packer, Milton
    Pfeffer, Marc A.
    Pieske, Burkert
    Redfield, Margaret M.
    Rouleau, Jean L.
    van Veldhuisen, Dirk J.
    Zannad, Faiez
    Zile, Michael R.
    McMurray, John J. V.
    Solomon, Scott D.
    JACC-HEART FAILURE, 2019, 7 (10) : 862 - 874
  • [47] CARDIOVASCULAR AND RENAL OUTCOMES OF MINERALOCORTICOID RECEPTOR ANTAGONIST USE IN PARAGON-HF
    Jering, Karola
    Mc Causland, Finnian
    Zannad, Faiez
    Claggett, Brian
    Lefkowitz, Marty
    Pieske, Burkert Mathias
    Rouleau, Jean L.
    Shi, Victor
    Ben-Gal, Turia
    Lam, Carolyn
    Shah, Sanjiv
    McMurray, John
    Solomon, Scott D.
    Pfeffer, Marc A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1030 - 1030
  • [48] Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF
    Jering, Karola S.
    Zannad, Faiez
    Claggett, Brian
    Mc Causland, Finnian R.
    Ferreira, Joao Pedro
    Desai, Akshay
    Barkoudah, Ebrahim
    McMurray, John J. V.
    Pfeffer, Marc A.
    Solomon, Scott D.
    JACC-HEART FAILURE, 2021, 9 (01) : 13 - 24
  • [49] PARAGON-HF - Why We Do Randomized, Controlled Clinical Trials
    O'Connor, Christopher M.
    deFilippi, Christopher
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (17): : 1675 - 1676
  • [50] Determinants of Right Ventricular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial Experience
    Lu, Henri
    Inciardi, Riccardo M.
    Abanda, Martin
    Shah, Amil M.
    Cikes, Maja
    Claggett, Brian
    Prasad, Narayana
    Lam, Carolyn S.
    Redfield, Margaret M.
    McMurray, John J.
    Solomon, Scott
    Hegde, Sheila
    Skali, Hicham
    CIRCULATION, 2023, 148
12345